Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 3/2006

01-06-2006 | Clinical trial

Expression and Clinical Signification of Cytosolic Hyaluronan Levels in Invasive Breast Cancer

Authors: María D. Corte, L.O. González, Mª Luz Lamelas, Ana Alvarez, Sara Junquera, Mª Teresa Allende, José L. García-Muñiz, Juan Argüelles, Francisco J. Vizoso

Published in: Breast Cancer Research and Treatment | Issue 3/2006

Login to get access
Metadata
Title
Expression and Clinical Signification of Cytosolic Hyaluronan Levels in Invasive Breast Cancer
Authors
María D. Corte
L.O. González
Mª Luz Lamelas
Ana Alvarez
Sara Junquera
Mª Teresa Allende
José L. García-Muñiz
Juan Argüelles
Francisco J. Vizoso
Publication date
01-06-2006
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2006
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-005-9130-7

Other articles of this Issue 3/2006

Breast Cancer Research and Treatment 3/2006 Go to the issue

Letter to the Editor

Comment to Anderson WF, Jatoi I, Devesa SS: Distinct Breast Cancer Incidence and Prognostic Patterns in the NCI’s SEER Program: Suggesting a Possible Link Between Etiology and Outcome. Breast Cancer Res Treat 90:127–137, 2005

Preclinical Study

Genome-Wide Analysis for Loss of Heterozygosity in Primary and Recurrent Phyllodes Tumor and Fibroadenoma of Breast using Single Nucleotide Polymorphism Arrays

Letter to the editor

Styrene and breast cancer incidence in Texas: a comment on an ecological association

OriginalPaper

A Cohort Study of Antihypertensive Medication Use and Breast Cancer Among Danish Women

Epidemiology

Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women

Preclinical study

Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits